Corvus Pharmaceuticals closes $201 million stock offering Jan 23, 2026 05:00PM
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approxim Jan 23, 2026 05:00PM
Corvus Pharmaceuticals prices $175 million stock offering Jan 21, 2026 10:54PM
Corvus Pharmaceuticals prices $175 million stock offering at $22.15 per share Jan 21, 2026 10:54PM
Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock Jan 21, 2026 10:53PM


Jan 21, 2026 10:53PM Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
Jan 20, 2026 04:01PM Corvus Pharmaceuticals announces $150 million public offering
Jan 20, 2026 04:01PM Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Sep 16, 2024 06:48AM Corvus Pharmaceuticals (CRVS) PT Raised to $21 at Ladenburg Thalmann
Oct 7, 2022 07:01AM Ladenburg Thalmann Starts Corvus Pharmaceuticals (CRVS) at Buy